These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15667388)

  • 1. From aspiration to achievement: assessment and noninvasive treatment of erectile dysfunction in aging men.
    Seftel AD
    J Am Geriatr Soc; 2005 Jan; 53(1):119-30. PubMed ID: 15667388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes Study.
    Stephenson RA; Mori M; Hsieh YC; Beer TM; Stanford JL; Gilliland FD; Hoffman RM; Potosky AL
    J Urol; 2005 Aug; 174(2):646-50; discussion 650. PubMed ID: 16006930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
    Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
    BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase type 5 inhibitors' extended duration of response as a variable in the treatment of erectile dysfunction.
    Dunn ME; Althof SE; Perelman MA
    Int J Impot Res; 2007; 19(2):119-23. PubMed ID: 16738695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro response of corpus cavernosum to phosphodiesterase-5 inhibition in the hypercholesterolaemic rabbit.
    Firoozi F; Longhurst PA; White MD
    BJU Int; 2005 Jul; 96(1):164-8. PubMed ID: 15963142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 5 phosphodiesterase inhibitors in the treatment of erectile dysfunction and cardiovascular disease.
    Ravipati G; McClung JA; Aronow WS; Peterson SJ; Frishman WH
    Cardiol Rev; 2007; 15(2):76-86. PubMed ID: 17303994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials.
    Blonde L
    Curr Med Res Opin; 2006 Nov; 22(11):2111-20. PubMed ID: 17076971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST
    Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New achievement and novel therapeutic applications of PDE5 inhibithors in older males.
    Frajese GV; Pozzi F
    J Endocrinol Invest; 2005; 28(3 Suppl):45-50. PubMed ID: 16042360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary on adjunctive use of testosterone gel with sildenafil for erectile dysfunction.
    Morales A
    J Urol; 2008 May; 179(5 Suppl):S103. PubMed ID: 18405738
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of endothelial dysfunction in the pathophysiology of erectile dysfunction in diabetes and in determining response to treatment.
    Pegge NC; Twomey AM; Vaughton K; Gravenor MB; Ramsey MW; Price DE
    Diabet Med; 2006 Aug; 23(8):873-8. PubMed ID: 16911625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy.
    Nehra A; Grantmyre J; Nadel A; Thibonnier M; Brock G
    J Urol; 2005 Jun; 173(6):2067-71. PubMed ID: 15879836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erectile dysfunction in aging men: testosterone role in therapeutic protocols.
    Caretta N; Ferlin A; Palego PF; Foresta C
    J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):108-11. PubMed ID: 16760637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent insights into androgen action on the anatomical and physiological substrate of penile erection.
    Gooren LJ; Saad F
    Asian J Androl; 2006 Jan; 8(1):3-9. PubMed ID: 16372114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on oral treatments for male erectile dysfunction.
    Kalsi JS; Kell PD
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):267-74. PubMed ID: 15096134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does testosterone have a role in erectile function?
    Mikhail N
    Am J Med; 2006 May; 119(5):373-82. PubMed ID: 16651047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase type 5 inhibitors for erectile dysfunction.
    Carson CC; Lue TF
    BJU Int; 2005 Aug; 96(3):257-80. PubMed ID: 16042713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sildenafil: a revolutionary therapy?
    Marshall SM
    Diabet Med; 1998 Nov; 15(11):897-9. PubMed ID: 9827843
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat.
    Ferrini MG; Kovanecz I; Sanchez S; Vernet D; Davila HH; Rajfer J; Gonzalez-Cadavid NF
    Biol Reprod; 2007 May; 76(5):915-23. PubMed ID: 17287493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction.
    Briganti A; Salonia A; Gallina A; Saccà A; Montorsi P; Rigatti P; Montorsi F
    Nat Clin Pract Urol; 2005 May; 2(5):239-47. PubMed ID: 16474835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.